DJO reported 3Q19 orthopedic revenue of USD $97.9 million, +5.9% vs. 3Q18.
Colfax leadership says it is off to a strong start implementing operational efficiencies at DJO through their CBS program Surgeon conversions and new products like the AltiVate shoulder, EMPOWR Knee and AltiVate Reverse Short Stem drove joint replacement revenue growth Leadership believes it can sustain consistent high single-digit growth for joint replacement The company is actively working a “healthy funnel” of bolt-on acquisitions to accelerate growth in 2020 ORTHOWORLD projects DJO full year 2019 orthopedic revenue of $411.2 million, +5.5% vs. 2018 Revenue Data All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales 3Q19 3Q18 $ Chg % Chg Joint Replacement $75.9 $70.9 $5.0 7.1% Knees $19.5 $18.5 $1.0 5.6% Hips $16.7 $16.1 $0.7 4.3% Extremities $39.6 $36.4 $3.3 9% Other (Recovery Sciences) $22.0 $21.5 $0.5 2.3% Total $97.9 $92.4 $5.5 5.9%
9Mo 19 9Mo 18 $ Chg % Chg Joint Replacement $230.5 $217.7 $12.7 5.9% Knees $59.9 $56.8 $3.1 5.5% Hips $51.0 $49.3 $1.7 3.5% Extremities $119.5 $111.6 $7.9 7.1% Other (Recovery Sciences) $64.4 $65.5 ($1.1) (1.6%) Total $294.9 $283.2 $11.7 4.1%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email .
Favorite
DJO reported 3Q19 orthopedic revenue of USD $97.9 million, +5.9% vs. 3Q18.
Colfax leadership says it is off to a strong start implementing operational efficiencies at DJO through their CBS program
DJO reported 3Q19 orthopedic revenue of USD $97.9 million, +5.9% vs. 3Q18.
Colfax leadership says it is off to a strong start implementing operational efficiencies at DJO through their CBS program Surgeon conversions and new products like the AltiVate shoulder, EMPOWR Knee and AltiVate Reverse Short Stem drove joint replacement revenue growth Leadership believes it can sustain consistent high single-digit growth for joint replacement The company is actively working a “healthy funnel” of bolt-on acquisitions to accelerate growth in 2020 ORTHOWORLD projects DJO full year 2019 orthopedic revenue of $411.2 million, +5.5% vs. 2018 Revenue Data All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales 3Q19 3Q18 $ Chg % Chg Joint Replacement $75.9 $70.9 $5.0 7.1% Knees $19.5 $18.5 $1.0 5.6% Hips $16.7 $16.1 $0.7 4.3% Extremities $39.6 $36.4 $3.3 9% Other (Recovery Sciences) $22.0 $21.5 $0.5 2.3% Total $97.9 $92.4 $5.5 5.9%
9Mo 19 9Mo 18 $ Chg % Chg Joint Replacement $230.5 $217.7 $12.7 5.9% Knees $59.9 $56.8 $3.1 5.5% Hips $51.0 $49.3 $1.7 3.5% Extremities $119.5 $111.6 $7.9 7.1% Other (Recovery Sciences) $64.4 $65.5 ($1.1) (1.6%) Total $294.9 $283.2 $11.7 4.1%
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email .
Favorite You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
